Skip to content

Papuan Indigenous Model of Male Circumcision

The Papuan Indigenous Model of Voluntary Clinical Male Circumcision

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06212531
Enrollment
239
Registered
2024-01-19
Start date
2020-09-07
Completion date
2023-08-31
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV Prevention, Male circumcision, Papua Indonesia

Brief summary

The purpose of the study is: AIM 1: To engage Papuan community members to explore acceptability, barriers and facilitators for introducing a school-based age and culturally appropriate, comprehensive VMMC intervention to reduce HIV incidence in the Papuan population. AIM 2: To assess the capacity of the community health system to meet international criteria for safe comprehensive VMMC services and to ensure the availability of resources and training necessary to meet these criteria in selected clinics. AIM 3: To design the PIM of school-based adolescent VMMC based on information collected in Aims 1 and 2 and in consultation with a community advisory board, the Ministry of Health and the Ministry of Education. AIM 4: To pilot-test the school-based PIM Intervention of VMMC with 400 boys ages 12-18 years at two HIV high-risk Papuan locations: the Nabire and Jayapura. Primary outcomes are the proportion of adolescent males exposed to school-based PIM VMMC educational and informational sessions who get circumcised and surgical event safety. Secondary outcomes are satisfaction by adolescent males and parents, any sexual activity within 6 weeks after circumcision, changes in sexual risk behaviors between base-line and 12 weeks after circumcision, and perceptions of providers regarding MC training and implementation, ease of device use, and challenges encountered.

Interventions

PROCEDUREMedical male circumcision using standard surgical technique.

Medical male circumcision using the WHO standard technique followed by examination of wound healing and behavioral risk assessment.

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
Atma Jaya Catholic University of Indonesia
CollaboratorOTHER
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Observational study of recruitment of young Papuan men who volunteer for medical male circumcision.

Eligibility

Sex/Gender
ALL
Age
15 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Resident of either Nabiri or Jayapura Districts of Papua, Indonesia. Able to provide informed consent if over 17 and parental consent and personal assent if less than 18. Focus group and interview participants had to be either a parent, boy or girl between 12-18, teacher or administrator, or community leader. To be eligible for circumcision, a boy had to be uncircumcised, age 15 years or above, and not show signs or symptoms of an STI or any penile abnormality (e.g., hypospadias, phimosis) that made him clinically ineligible for circumcision.

Exclusion criteria

* Unable to provide informed consent or assent. Any medical condition indicating should not undergo circumcision.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of male exposed to intervention who get circumcised.6 monthsThe proportion of males who are recorded attending school-based PIM VMMC educational and informational sessions who are recorded as getting circumcised and at community health clinics.

Secondary

MeasureTime frameDescription
Levels Satisfaction4 monthsLevels of satisfaction by adolescent males and parents measured through face-to-face interview questionnaires using a five item likert scale.
Sexual Behavior4 monthsSexual activity within the first 6 weeks after circumcision measured by face-to-face interview, including whether or not they have had sex, number of sex partners and condom use.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026